Discussion
“You are very strong.” People say this as if it’s a compliment. Sometimes when I hear it, I smile back at them and mutter, “Thank…
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
While myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Discussion
“You are very strong.” People say this as if it’s a compliment. Sometimes when I hear it, I smile back at them and mutter, “Thank…
Two combination therapies using Blenrep (belantamab mafodotin) — designed to treat adults with relapsed or refractory multiple myeloma — have been approved in the…
Discussion
When I wake up in the morning, I do the same things in the same order: Examine the pillbox. Send a text to my mum…
Ichnos Glenmark Innovation (IGI) is partnering with Abbvie to advance the development of ISB 2001, a multiple myeloma treatment candidate that’s now in…
Discussion
I have quite a lot of friends who are caregivers like me. Every day and night, they provide care, attention, and company to their patients,…
The U.S. Food and Drug Administration (FDA) has approved label updates for two Bristol Myers Squibb (BMS) CAR T-cell therapies, both for the treatment…
Don't have an account?
|
Already have an account?
Create your account by filling in the information below:
By creating an account, you are agreeing to the Privacy Policy and Terms of Service.